Skip to main content

Douglass Winthrop Advisors, LLC

Position in NVS — Novartis AG

CIK 1308527 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,372,083
-$130,671 QoQ
Shares Held
8,755
-11.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#529
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. NVS ranks #5 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVS
Novartis AG
This page
8,755 $1,372,083

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,372,083 8,755
2026-03-31 $1,502,754 9,838
2025-12-31 $1,356,365 9,838
2025-09-30 $1,235,977 9,638
2025-06-30 $820,568 6,781
2025-03-31 $755,945 6,781
2024-12-31 $666,670 6,851
2024-09-30 $806,060 7,008
2024-06-30 $746,071 7,008
2024-03-31 $691,426 7,148
2023-12-31 $700,529 6,938
2023-09-30 $706,704 6,938
2023-06-30 $700,113 6,938
2023-03-31 $638,296 6,938
2022-12-31 $629,415 6,938
2022-09-30 $588,165 7,738
2022-06-30 $835,832 9,888
2022-03-31 $835,029 9,516
2021-12-31 $832,364 9,516
2021-09-30 $1,170,108 14,308
2021-06-30 $1,337,395 14,658
2021-03-31 $1,295,705 15,158
2020-12-31 $1,647,520 17,447
2020-09-30 $1,571,541 18,072
2020-06-30 $896,981 10,270
2020-03-31 $1,044,641 12,670